Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cannabis - search results
If you're not happy with the results, please do another search
MHL Series B equity financing and global CPG partnerships
Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.
Stop drug testing and start impairment testing
A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
Lifescience Legal Design
Here, Lifescience Legal Design discuss the legal status of CBD and hemp in the European Union.
AI algorithm to identify homeless youth at risk of substance abuse
Researchers at the College of Information Sciences and Technology at Penn State have developed an artificial intelligence (AI) algorithm to help identify homeless youth at risk of substance abuse.
The European Commission’s ‘pause’ on CBD novel food applications
Associate, David Hardstaff and Partner, John Binns at BCL Solicitors LLP, explain here how cannabis wonder child takes a knock in light of the European Commission’s ‘pause’ on CBD novel food applications mean for this booming industry.
Can CBD restore your hormonal imbalance?
Lorraine Clark, Director of hapihemp, explores whether CBD oil can be used to restore hormonal imbalances.
EUMCA: Limit of 0.2% THC in CBD products should not change
Chair of the European Medicinal Cannabis Association (EUMCA) issues warning that raising limit for THC in CBD to 0.3% will risk patient safety.
Expanding the portfolio of rigorous cannabinoid research with new funding opportunities
David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health, discusses new funding opportunities for cannabinoid research.
Greenheart CBD: A green crop from seed to shelf
Here, we learn how about a different kind of green crop that grows in Ireland and the journey of that from seed to shelf as part of the Greenheart CBD story.
Attracting major investors: GreenLight on the international stage
In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.
Essential oils as a potential modulator of the endocannabinoid system
Dr Christian Löfke, responsible for research and product development at BioBloom, walks us through the rudiments of essential oils as a potential modulator of the endocannabinoid system.
Cannabinoids in medicine part 5: Treating COVID-19
In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.
CBDepot: The company with a “Valid” Novel Food Application
Here, CBDepot discuss how they worked with the European Commission to achieve a “valid” Novel Food Application.
Can cannabidiol (CBD) treat epilepsy?
Here, OilsBySimpson Founder Kevin William Simpson, explains what current research shows about CBD’s effect on epilepsy and its applications as a treatment.
Lifescience Legal Design
Here, Lifescience Legal Design analyse the current situation of medical cannabis and hemp regulation, discussing the ongoing plans of the US, UK and the EU.
Cannabinoid products: Create the best organic hemp products for the mass market
A worldwide manufacturer and distributor of cannabinoid products, Elixinol are committed to creating the best organic hemp products for the mass market.
EU crackdown: Novel food regulation of CBD
Here, European Union (EU) Novel Food regulations are thoroughly explored and questioned in the context of CBD in food.
Why patient advocates are key to growing CBD brands
Here, we discuss how unregulated industry patient advocates are integral to strengthening the credibility of growing CBD brands.
The NIHR Health Technology Assessment Programme: Research needed by the NHS
Professor Hywel C. Williams, Director of the NIHR Health Technology Assessment (HTA) Programme, sheds light on the HTA Programme that is pushing and pulling research that is needed by the UK National Health Service.
Cannyx Markets UK Ltd: The globalisation of the CBD industry
Here, Hassan Akhtar explains how Cannyx Markets UK Ltd. Are successfully navigating the globalisation of the CBD industry.